The Influence of Anterior Chamber Fluid Mediators on the Success Rate of Trabeculectomy
1 other identifier
observational
62
1 country
1
Brief Summary
The aim of the study is to investigate whether it is possible to predict the success of trabeculectomy in patients with glaucoma through the examination of mediators of wound healing in anterior chamber fluid. The success rate of trabeculectomy with mitomycin C in the literature is about 75%. This leads on the question why 25% of the patients received trabeculectomy are not sufficient treated and have not a long-term IOP reduction. Precisely this question is to be examined by the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2009
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
May 3, 2010
CompletedFirst Posted
Study publicly available on registry
May 4, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2012
CompletedNovember 20, 2018
November 1, 2018
3 months
May 3, 2010
November 16, 2018
Conditions
Keywords
Study Arms (1)
Glaucoma patients
Interventions
Eligibility Criteria
Patients from the University Eye Hospital of Cologne
You may qualify if:
- patients with glaucoma with a trabeculectomy required
- eyes of 60 patients, The ratio of female / male is not involved.
- Eye pressure under local therapy: 20mmHg and above (corrected with pachymetry table).
- age of at least 18 years
You may not qualify if:
- less than 50yl anterior chamber fluid could be collected during the operation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Eye Hospital, University of Cologne
Cologne, North Rhine-Westphalia, 50937, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Arno Hueber
Study Record Dates
First Submitted
May 3, 2010
First Posted
May 4, 2010
Study Start
October 1, 2009
Primary Completion
January 1, 2010
Study Completion
March 1, 2012
Last Updated
November 20, 2018
Record last verified: 2018-11